Compare Kurniamitra Duta Sentosa Tbk. (KMDS) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kurniamitra Duta Sentosa Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Kurniamitra Duta Sentosa Tbk. trades at Rp525 (market cap 416B, 32K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 651.75B, 130K 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and UBC Medical Indonesia Tbk. is more actively traded (130K versus 32K). Which is the better fit depends on your goals.
| KMDS | LABS | |
|---|---|---|
Market Cap | 416B | 651.75B |
Volume | 32K | 130K |
Lot | 320 | 1.3K |
Turnover | 16.67M | 21.42M |
Average Price | 521.06 | 164.75 |
Value | 16.67M | 21.42M |
Indicative Equilibrium Price | — | 165 |
Indicative Equilibrium Volume | — | 300 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kurniamitra Duta Sentosa Tbk.
PT Kurniamitra Duta Sentosa Tbk ("Company") was established based on Deed No. 21 July 17, 2000, which was made before the Notary Kun Hidayat, SH. The company started its commercial operations since July 17, 2000
Read more on KMDS →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
